This report, supported by the DCP3 Country Translation Project, presents a comprehensive analysis of the revenue potential, viability, and health system impact associated with the potential introduction of a Revolving Drug Fund and cost-sharing mechanisms within the Liberian health system.
- Analyses Liberia's health financing landscape in the public sector to identify resource gaps.
- Assesses the revenue potential, viability, and health systems impact of the RDF at primary health facilities and cost-sharing at secondary level facilities.
- Determines affordable prices for medicines and services within the Essential Package for UHC.
- Presents the financial resources required from various sources to cover the costs of medicines and services at primary and secondary levels.